Schedule 13G ownership disclosure
Amicus Therapeutics Inc
Common Stock, par value $0.01 per share · CUSIP: 03152W109
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avoro Capital Advisors LLC
Shares: 20,500,000.00 · Class: 6.7%
- Behzad Aghazadeh
Shares: 20,500,000.00 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-002354
- Form type
- SCHEDULE 13G/A
- Filer
- AMICUS THERAPEUTICS, INC.
- CIK
- CIK 1178879
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership